Centene Expects To Report Q2 GAAP EPS Of $2.16 And Adjusted EPS Of $2.42 (Est $1.96), Inclusive Of 2023 Risk Adjustment Outperformance
$CNC
Medical Specialities
Health Care
On July 22, 2024, the Centers for Medicare and Medicaid Services (CMS) published the final risk adjustment transfers for the 2023 benefit year, resulting in a final $0.0 billion receivable for Centene.
As a result of the publication of the benefit year 2023 reports, the Company is providing information regarding Centene's estimated net risk adjustment payable as of March 31, 2024, as well as summarizing the second quarter and expected full year 2024 financial impact of the 2023 risk adjustment results.
As of March 31, 2024, Centene had recorded a $1.3 billion 2023 risk adjustment payable, net on the Consolidated Balance Sheet.